• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于阳性淋巴结对数优势比的列线图预测T3和T4期胆囊癌患者根治性切除术后的癌症特异性生存情况

Nomogram Based on Log Odds of Positive Lymph Nodes Predicting Cancer-Specific Survival in Patients With T3 and T4 Gallbladder Cancer After Radical Resection.

作者信息

Yuan Chen, Tao Qiaomeng, Wang Jian, Wang Kai, Zou Shubing, Hu Zhigang

机构信息

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Front Surg. 2021 Oct 27;8:675661. doi: 10.3389/fsurg.2021.675661. eCollection 2021.

DOI:10.3389/fsurg.2021.675661
PMID:34778352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8578716/
Abstract

The aim of this study based on log odds of positive lymph nodes (LODDS) is to develop and validate an effective prognostic nomogram for patients with T3 and T4 gallbladder cancer (GBC) after resection. A total of 728 T3 and T4 gallbladder cancer patients after resection from the Surveillance, Epidemiology, and End Results (SEER) database, randomly divided into training cohort and validation cohort according to 7:3. Another 128 patients from The Second Affiliated Hospital of Nanchang University for external validation. The nomograms were built by the Cox regression model and the Fine and Grey's model. Concordance index (C-index), calibration curve and the area under receiver operating characteristic (ROC) curve (AUC) were used to evaluate the nomogram and internal verification. The decision curve analysis (DCA) was used to measure clinical applicability. LODDS was independent prognostic predictor for overall survival (OS) and cancer-specific survival (CSS), and established the nomograms on this basis. The nomogram we have established has a good evaluation effect, with a C-index of 0.719 (95%CI, 0.707-0.731) for OS and 0.747 (95%CI, 0.733-0.760) for CSS. The calibration curves of OS and CSS both showed good calibration capability, and the AUC for predicting 1-, 2-, and 3-year 0.858, 0.848 were and 0.811 for OS, and 0.794, 0.793, and 0.750 for CSS. The DCA of nomograms both showed good clinical applicability. The nomogram can provide effective OS and CSS prediction for patients with advanced gallbladder cancer after surgery.

摘要

本项基于阳性淋巴结对数优势比(LODDS)的研究旨在开发并验证一种针对T3和T4期胆囊癌(GBC)患者术后有效的预后列线图。从监测、流行病学和最终结果(SEER)数据库中选取了728例T3和T4期胆囊癌术后患者,按照7:3随机分为训练队列和验证队列。另外从南昌大学第二附属医院选取128例患者进行外部验证。通过Cox回归模型和Fine与Grey模型构建列线图。采用一致性指数(C指数)、校准曲线和受试者工作特征曲线(ROC)下面积(AUC)对列线图进行评估和内部验证。采用决策曲线分析(DCA)来衡量临床适用性。LODDS是总生存期(OS)和癌症特异性生存期(CSS)的独立预后预测指标,并在此基础上建立了列线图。我们建立的列线图具有良好的评估效果,OS的C指数为0.719(95%CI,0.707 - 0.731),CSS的C指数为0.747(95%CI,0.733 - 0.760)。OS和CSS的校准曲线均显示出良好的校准能力,OS预测1年、2年和3年的AUC分别为0.858、0.848和0.811,CSS预测1年、2年和3年的AUC分别为0.794、0.793和0.750。列线图的DCA均显示出良好的临床适用性。该列线图可为晚期胆囊癌术后患者提供有效的OS和CSS预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/0848ce261b20/fsurg-08-675661-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/be9b670dbb62/fsurg-08-675661-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/0b27cf95f846/fsurg-08-675661-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/113bf69dc0e5/fsurg-08-675661-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/6ada86f5afec/fsurg-08-675661-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/9e838f86a379/fsurg-08-675661-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/a85e1c988e56/fsurg-08-675661-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/aea9f84a5f36/fsurg-08-675661-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/0848ce261b20/fsurg-08-675661-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/be9b670dbb62/fsurg-08-675661-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/0b27cf95f846/fsurg-08-675661-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/113bf69dc0e5/fsurg-08-675661-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/6ada86f5afec/fsurg-08-675661-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/9e838f86a379/fsurg-08-675661-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/a85e1c988e56/fsurg-08-675661-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/aea9f84a5f36/fsurg-08-675661-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/8578716/0848ce261b20/fsurg-08-675661-g0008.jpg

相似文献

1
Nomogram Based on Log Odds of Positive Lymph Nodes Predicting Cancer-Specific Survival in Patients With T3 and T4 Gallbladder Cancer After Radical Resection.基于阳性淋巴结对数优势比的列线图预测T3和T4期胆囊癌患者根治性切除术后的癌症特异性生存情况
Front Surg. 2021 Oct 27;8:675661. doi: 10.3389/fsurg.2021.675661. eCollection 2021.
2
Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.基于阳性淋巴结对数优势构建并验证列线图预测甲状腺髓样癌术后预后
Ann Surg Oncol. 2021 Aug;28(8):4360-4370. doi: 10.1245/s10434-020-09567-3. Epub 2021 Jan 19.
3
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.阴性淋巴结对数比值/T分期作为根治性膀胱切除术后膀胱癌患者新的预后因素的预测价值。
Front Oncol. 2022 Jul 19;12:895413. doi: 10.3389/fonc.2022.895413. eCollection 2022.
4
Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.基于阳性淋巴结对数比值(LODDS)的列线图在预测卵巢透明细胞癌患者总生存期和癌症特异性生存期方面的构建与验证
Front Oncol. 2024 Mar 21;14:1370272. doi: 10.3389/fonc.2024.1370272. eCollection 2024.
5
A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery.一项来自监测、流行病学和最终结果(SEER)数据库的新型列线图,用于预测胆囊癌患者术后的预后。
Ann Transl Med. 2019 Dec;7(23):738. doi: 10.21037/atm.2019.11.112.
6
A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.一种基于对数优势比(LODDS)的新型列线图,用于预测上皮性卵巢癌的预后。
Oncotarget. 2017 Jan 31;8(5):8120-8130. doi: 10.18632/oncotarget.14100.
7
Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.基于淋巴结转移指标的膀胱癌患者预后列线图:一项 SEER 人群研究和外部验证。
Cancer Med. 2023 Mar;12(6):6853-6866. doi: 10.1002/cam4.5475. Epub 2022 Dec 7.
8
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.基于监测、流行病学和最终结果数据库及单中心数据的可切除非小细胞肺癌伴淋巴结转移(N1或N2)患者生存列线图模型
Transl Lung Cancer Res. 2024 Mar 29;13(3):573-586. doi: 10.21037/tlcr-24-119. Epub 2024 Mar 27.
9
Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.基于手术治疗后淋巴结阳性对数优势比预测子宫内膜癌肉瘤患者总生存期的列线图。
BMC Cancer. 2021 Oct 27;21(1):1149. doi: 10.1186/s12885-021-08888-0.
10
Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.预测有淋巴结转移的宫颈癌患者总生存期和癌症特异性生存期的新型列线图的开发与验证
Front Oncol. 2022 Mar 17;12:857375. doi: 10.3389/fonc.2022.857375. eCollection 2022.

引用本文的文献

1
Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population.基于大样本量的远处转移性肝内胆管细胞癌患者预后预测列线图的建立和外部验证。
BMC Cancer. 2024 Feb 16;24(1):227. doi: 10.1186/s12885-024-11976-6.
2
A nomogram based on the log odds of positive lymph nodes for predicting the prognosis of T1 stage rectal cancer.一种基于阳性淋巴结对数几率的列线图,用于预测T1期直肠癌的预后。
Am J Cancer Res. 2023 Apr 15;13(4):1498-1508. eCollection 2023.
3
Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study.

本文引用的文献

1
A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer.一种预测胆囊癌切除患者癌症特异性生存的新型分期系统。
Front Oncol. 2020 Jul 28;10:1281. doi: 10.3389/fonc.2020.01281. eCollection 2020.
2
Prognostic Evaluation for Patients over 45 Years Old with Gallbladder Adenocarcinoma Resection: A SEER-Based Nomogram Analysis.基于 SEER 数据库的列线图分析:45 岁以上胆囊腺癌切除术患者的预后评估。
Biomed Res Int. 2020 Jul 18;2020:6370946. doi: 10.1155/2020/6370946. eCollection 2020.
3
A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery.
胆囊黏液腺癌患者预后列线图的开发与验证:一项基于人群的研究。
Front Oncol. 2022 Dec 14;12:1084445. doi: 10.3389/fonc.2022.1084445. eCollection 2022.
4
A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery.基于阳性淋巴结对数优势的新型列线图预测非转移性胆囊腺癌手术后的生存情况。
Sci Rep. 2022 Oct 1;12(1):16466. doi: 10.1038/s41598-022-20933-x.
一项来自监测、流行病学和最终结果(SEER)数据库的新型列线图,用于预测胆囊癌患者术后的预后。
Ann Transl Med. 2019 Dec;7(23):738. doi: 10.21037/atm.2019.11.112.
4
Prognostic Model to Predict Cancer-Specific Survival for Patients With Gallbladder Carcinoma After Surgery: A Population-Based Analysis.预测胆囊癌患者术后癌症特异性生存的预后模型:一项基于人群的分析。
Front Oncol. 2019 Dec 12;9:1329. doi: 10.3389/fonc.2019.01329. eCollection 2019.
5
Gallbladder cancer: epidemiology and genetic risk associations.胆囊癌:流行病学与遗传风险关联
Chin Clin Oncol. 2019 Aug;8(4):31. doi: 10.21037/cco.2019.08.13.
6
Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis.预测食管腺癌患者癌症特异性死亡率的列线图:一项竞争风险分析
J Thorac Dis. 2019 Jul;11(7):2990-3003. doi: 10.21037/jtd.2019.07.56.
7
Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.列线图的建立与验证:用于预测 IV 期结直肠癌患者的总生存期和癌症特异性生存期。
Jpn J Clin Oncol. 2019 May 1;49(5):438-446. doi: 10.1093/jjco/hyz035.
8
A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database.基于监测、流行病学和最终结果(SEER)数据库的宫颈癌术后预后列线图
J Cancer. 2018 Oct 10;9(21):3923-3928. doi: 10.7150/jca.26220. eCollection 2018.
9
Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder.预测膀胱原发性小细胞癌患者个体预后的列线图
J Cancer. 2018 Mar 8;9(7):1152-1164. doi: 10.7150/jca.23344. eCollection 2018.
10
Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.2003-2015 年期间中国癌症生存率变化:基于 17 个癌症登记处的汇总分析。
Lancet Glob Health. 2018 May;6(5):e555-e567. doi: 10.1016/S2214-109X(18)30127-X.